Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jeremy Wu, Zhenhua"'
Autor:
Korpal, Manav, Puyang, Xiaoling, Jeremy Wu, Zhenhua, Seiler, Roland, Furman, Craig, Oo, Htoo Zarni, Seiler, Michael, Irwin, Sean, Subramanian, Vanitha, Julie Joshi, Jaya, Wang, Chris K., Rimkunas, Victoria, Tortora, Davide, Yang, Hua, Kumar, Namita, Kuznetsov, Galina, Matijevic, Mark, Chow, Jesse, Kumar, Pavan, Zou, Jian
Publikováno v:
Nature Communications; 7/24/2017, Vol. 8 Issue 1, pN.PAG-N.PAG, 1p
Autor:
Morgan E. Roberts, Pete Smith, Manav Korpal, Markus Warmuth, Mark Matijevic, Bernhard Kiss, Ming-Hong Hao, Jesse Chow, Zhenhua Jeremy Wu, Ryan Henry, Jian Zou, Peter Fekkes, Nicholas A. Larsen, Pavan Kumar, Mads Daugaard, Lihua Yu, Kristjan Bloudoff, Allison Davis, Victoria Rimkunas, Jaya Julie Joshi, Sean Irwin, Michael Seiler, Craig Furman, Namita Kumar, Laura Corson, Xiaoling Puyang, Peter C. Black, Htoo Zarni Oo, V. Subramanian, Davide Tortora, Anand Selvaraj, Galina Kuznetsov, Hua Yang, Ladan Fazli, Jacob Feala, Chris K. Wang, Roland Seiler, James Douglas, Ping Zhu
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-14 (2017)
Korpal, Manav; Puyang, Xiaoling; Jeremy Wu, Zhenhua; Seiler, Roland; Furman, Craig; Oo, Htoo Z; Seiler, Michael; Irwin, Sean; Subramanian, Vanitha; Julie Joshi, Jaya; Wang, Chris K; Rimkunas, Victoria; Tortora, Davide; Yang, Hua; Kumar, Namita; Kuznetsov, Galina; Matijevic, Mark; Chow, Jesse; Kumar, Pavan; Zou, Jian; ... (2017). Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer. Nature communications, 8(1), p. 103. Nature Publishing Group 10.1038/s41467-017-00147-w
Nature Communications
Korpal, Manav; Puyang, Xiaoling; Jeremy Wu, Zhenhua; Seiler, Roland; Furman, Craig; Oo, Htoo Z; Seiler, Michael; Irwin, Sean; Subramanian, Vanitha; Julie Joshi, Jaya; Wang, Chris K; Rimkunas, Victoria; Tortora, Davide; Yang, Hua; Kumar, Namita; Kuznetsov, Galina; Matijevic, Mark; Chow, Jesse; Kumar, Pavan; Zou, Jian; ... (2017). Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer. Nature communications, 8(1), p. 103. Nature Publishing Group 10.1038/s41467-017-00147-w
Nature Communications
Muscle-invasive bladder cancer (MIBC) is an aggressive disease with limited therapeutic options. Although immunotherapies are approved for MIBC, the majority of patients fail to respond, suggesting existence of complementary immune evasion mechanisms